Article Image Jeffrey A. Singer, M.D., F.A.C.S. Board Certified General Surgeon

IPFS

Harm Reduction: Shifting from a War on Drugs to a War on Drug-Related Deaths - March 21, 8:15 a.m.

Written by Dr. Jeffrey Singer Subject: Conferences

Harm Reduction: Shifting from a War on Drugs to a War on Drug-Related Deaths– March 21, 8:15 a.m.

Date: Thursday, March 21st
 
Time: 8:15 a.m. to 3:15 p.m.
(Lunch will be provided)
 
Location: Hayek Auditorium
Cato Institute
1000 Massachusetts Ave
Washington, DC 20001
 
RSVP: Click here to register. 
 
Unlike prohibition, harm-reduction
strategies begin with the realistic and
nonjudgmental premise that there has
never been, and will never be, a drug
free society. This conference, featuring clinical and research experts in epidemiology, public health, addiction treatment, and harm reduction, will examine the record of various harm-reduction modalities in the developed world.

For more information about this event,
Click Here.

The event is open to the public and is free of charge. Click here to register.

Featuring: Cato's Jeffrey A. Singer, MD, Senior Fellow; Clark Neily, Vice President for Criminal Justice; Jeffrey Miron, Director of Undergraduate Economic Education, Harvard University; Director of Economic Studies; Trevor Burrus, Research Fellow, Robert A. Levy Center for Constitutional Studies; and Michael F. Cannon, Director, Health Policy Studies. Other speakers will include, Darwin Fisher, Program Manager/Clinic Coordinator, Insite; Edward G. Rendell, Former Governor of Pennsylvania; Maia Szalavitz, Award-winning author, neuroscience journalist, Soros Justice Fellow; Corey S. Davis, Deputy Director, Staff Attorney, Network for Public Health Law; Adrianne Wilson-Poe, Moron-Concepcion Laboratory, Washington University School of Medicine; Donald S. Burke, Dean, University of Pittsburgh Graduate School of Public Health; Daniel Ciccarone, Professor of Family and Community Medicine, University of California San Francisco Medical Center; Beau Kilmer, Senior Policy Researcher, RAND Corporation & Codirector, RAND Drug Policy Research Center; D. Scott MacDonald, Physician Lead, Providence Crosstown Clinic.

Share
Tweet
+1
 
Support Cato


Follow Cato on:

Facebook
Twitter
Google Plus

YouTube

thelibertyadvisor.com/declare